Navigation Links
James Briscoe awarded 2008 EMBO Gold Medal
Date:7/10/2008

The European Molecular Biology Organization (EMBO) announced that James Briscoe of the Medical Research Council's National Institute for Medical Research will receive the prestigious EMBO Gold Medal for 2008.

Briscoe receives the award in recognition of his discovery that cells integrate time of exposure and concentration of a morphogen to subsequently mount a graded response.

Awarded annually, the EMBO Gold Medal recognises the outstanding contributions of young researchers in the molecular life sciences. Widely regarded as the most prestigious award of its kind in Europe, the Gold Medal highlights the high standards of Europe's best scientists.

"James Briscoe has revolutionized our understanding of the specification of cell identity in a given spatial setting," said Hermann Bujard, EMBO Executive Director. "His work exemplifies how talented scientists are advancing the field of molecular biology."

Four years at Columbia University in New York as a postdoc in Thomas Jessell's lab laid the foundation for Briscoe's career as a developmental biologist. James says he "learned" developmental biology from working alongside Jessell and a "great" postdoc in the lab at the time, Johan Ericson.

While at Columbia University, Briscoe began to unravel the control mechanisms of neuronal cell identity in the ventral neural tube a research theme sustained in his own lab at NIMR since taking up a group leader position in 2000. Specifically, the Briscoe lab studies the central role of the morphogen Sonic Hedgehog (Shh) to specify the position and subtype identity of neurons in the ventral spinal cord.

"We want to understand how neurons - nerve cells are arranged in the spinal cord," explains the EMBO Gold Medal winner for audiences other than his peers. "Specifically we are looking at the molecular basis of how different neuronal cells are organized in a developing embryo as a result of signals received from an important molecule called Sonic Hedgehog, or Shh, that is secreted from a particular region in the spinal cord."

Briscoe and his group discovered a novel mechanism that allows cells to integrate the time of exposure and the concentration of the morphogen Shh to subsequently mount a graded response. In other words, different concentrations of the morphogen activate a signal within the receiving cell for different periods of times. Cells in turn respond to different durations of the signal by activating different genes and therefore becoming different types of nerve cells.

"The discovery that concentration is effectively converted into time is a major shift in our understanding of how a graded signal acts to regulate genes," stated David Wilkinson, Head of Genetics and Development at NIMR, in his nomination of Briscoe for the EMBO Gold Medal.

James Briscoe's contribution to the understanding of how cell identity is specified in a given spatial setting has established a new paradigm that may also apply in many other contexts. In addition to Shh, a number of other secreted molecules members of different protein families have also been implicated in acting as morphogens to pattern other tissues. "It is possible that other morphogens could use a similar mechanism to control cells, for example early in embryo development during gastrulation," explains the Gold Medal winner.

"James's discoveries have revealed general principles that may apply to many other contexts in which graded signals and downstream transcription factors control cell identity," confirmed David Wilkinson.

Robb Krumlauf, former Head of Division at NIMR who helped to recruit Briscoe to the institute, points out his outstanding qualities at the bench: "At NIMR James rapidly established an independent and creative line of research in his own group. His work is highly rigorous, hits the heart of a problem, and continues to be timely and of wide general interest."

Jim Smith of the Gurdon Institute agrees with Krumlauf that Briscoe's work "has been remarkably creative and imaginative while retaining characteristic levels of careful experimentation and scholarship."

On hearing the news of the EMBO Gold Medal Briscoe referred to the success of his team of researchers: "I have been very fortunate working with very talented and smart people. They taught me a lot, supported me fantastically, and made many significant contributions."

In 2000, James Briscoe was selected to benefit from the highly competitive EMBO Young Investigator Programme, then in its first year and now renowned for its scientific excellence.

James Briscoe will receive the EMBO Gold Medal and an award of 10,000 euro on 6 September 2008 at the EMBO Members Workshop, Frontiers of Molecular Biology, in Tampere, Finland.


'/>"/>

Contact: Suzanne Beveridge
communications@embo.org
49-622-188-91108
European Molecular Biology Organization
Source:Eurekalert

Related biology news :

1. NASA scientist James Hansen to speak at July 11 conference on Rejuvenating Public Sector Science
2. 12 McGill researchers awarded Canada Research Chairs
3. Anthony S. Fauci awarded Lasker Award for Public Service
4. ETH Zurich professor Ari Helenius awarded Benoist Prize
5. Nanobiosym awarded $2 million DTRA contract
6. Mustafa alAbsi Ph.D. and national team awarded major NIH grant
7. Parus Interactive Awarded Patent for Speech-Activated Remote System Management
8. $2.7 million awarded for metastatic colon cancer research
9. UCR researchers awarded nearly $1.7M to develop improved cowpea varieties
10. BIO-key(R) and Tiger IT Awarded a Follow-on Contract for Nationwide Voter / Citizen Registration in Bangladesh
11. University awarded £5M to investigate how cells communicate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL ... desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar ... 2017, con m├║ltiples sitios previstos a lo largo de Europa y ... MSC-1 es ... inhibidor de leucemia (LIF), una citoquina pleiotr├│pica que se sobreexpresa en ...
(Date:12/15/2016)... and BADEN-BADEN, Germany , December 15, ... global financial services provider, today announced an agreement with NuData ... biometrics, to join forces. The partnership will enable clients to ... in compliance with local data protection regulation. ... In order to provide ...
(Date:12/15/2016)... 2016  There is much more to innovative access ... engine. Continental will demonstrate the intelligence of today,s solutions ... . Through the combination of the keyless entry and ... elements, the international technology company is opening up new ... "The integration of biometric elements brings our ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... ... January 19, 2017 , ... DaVita Clinical ... spectrum of drug and device development, and Prism Clinical Research , a ... today announced Verified Clinical Trials (VCT) has been selected by both ...
(Date:1/19/2017)... N.Y. , Jan. 18, 2017 Acupath ... services, announces the formation of an Executive Committee that ... and beyond. John Cucci , a ... promoted from Director of Business Development to Chief ... 2015, Mr. Cucci served in senior sales leadership roles ...
(Date:1/18/2017)... January 18, 2017 According to a new market research ... Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic and Research Institutions) ... reach USD 739.9 Million by 2021 from USD 557.1 Million in 2016, growing ... ... MarketsandMarkets Logo ...
(Date:1/18/2017)... 2017   Parent Project Muscular Dystrophy (PPMD) , ... Duchenne muscular dystrophy (Duchenne) , today announced a $600,000 ... of Technology (NJIT) and Talem Technologies (Talem) as part ... to assist people living with Duchenne. PPMD is ... an embedded computer, software, a force sensor and a ...
Breaking Biology Technology: